Glob Bioenergi (ALGBE) - Cash Flow Conversion Efficiency

Latest as of December 2024: -3.463x

Based on the latest financial reports, Glob Bioenergi (ALGBE) has a cash flow conversion efficiency ratio of -3.463x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-5.86 Million ≈ $-6.85 Million USD) by net assets (€1.69 Million ≈ $1.98 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Glob Bioenergi - Cash Flow Conversion Efficiency Trend (2008–2024)

This chart illustrates how Glob Bioenergi's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read ALGBE current and long-term liabilities for a breakdown of total debt and financial obligations.

Glob Bioenergi Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Glob Bioenergi ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
PBT Group Ltd JSE:PBG	0.295x
China Liberal Education Holdings NASDAQ:CLEU	-0.015x
Windtree Therapeutics Inc NASDAQ:WINT	0.549x
Eden Research plc LSE:EDEN	-0.048x
LeddarTech Holdings Inc NASDAQ:LDTC	0.084x
AdCapital AG F:ADC	N/A
PT Sreeya Sewu Indonesia Tbk JK:SIPD	-0.047x
Southstone Minerals Ltd V:SML	-0.174x

Annual Cash Flow Conversion Efficiency for Glob Bioenergi (2008–2024)

The table below shows the annual cash flow conversion efficiency of Glob Bioenergi from 2008 to 2024. For the full company profile with market capitalisation and key ratios, see Glob Bioenergi market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€1.69 Million ≈ $1.98 Million	€-7.51 Million ≈ $-8.77 Million	-4.435x	-484.55%
2023-12-31	€10.41 Million ≈ $12.17 Million	€-7.90 Million ≈ $-9.23 Million	-0.759x	+42.83%
2022-12-31	€7.65 Million ≈ $8.94 Million	€-10.15 Million ≈ $-11.87 Million	-1.327x	-108.53%
2021-12-31	€18.66 Million ≈ $21.82 Million	€-11.88 Million ≈ $-13.88 Million	-0.636x	+75.39%
2020-12-31	€4.13 Million ≈ $4.83 Million	€-10.68 Million ≈ $-12.49 Million	-2.585x	-144.39%
2019-12-31	€9.71 Million ≈ $11.35 Million	€-10.27 Million ≈ $-12.01 Million	-1.058x	+10.43%
2018-12-31	€6.28 Million ≈ $7.34 Million	€-7.42 Million ≈ $-8.67 Million	-1.181x	-78.73%
2017-12-31	€13.72 Million ≈ $16.04 Million	€-9.07 Million ≈ $-10.60 Million	-0.661x	+33.80%
2016-12-31	€9.30 Million ≈ $10.87 Million	€-9.28 Million ≈ $-10.85 Million	-0.998x	+10.80%
2015-12-31	€7.90 Million ≈ $9.23 Million	€-8.84 Million ≈ $-10.33 Million	-1.119x	-176.09%
2014-12-31	€17.88 Million ≈ $20.91 Million	€-7.25 Million ≈ $-8.47 Million	-0.405x	-111.88%
2013-12-31	€23.77 Million ≈ $27.79 Million	€-4.55 Million ≈ $-5.32 Million	-0.191x	-70.32%
2012-12-31	€6.47 Million ≈ $7.57 Million	€-727.00K ≈ $-849.94K	-0.112x	+84.97%
2011-12-31	€3.95 Million ≈ $4.62 Million	€-2.95 Million ≈ $-3.45 Million	-0.747x	-98.98%
2010-12-31	€6.05 Million ≈ $7.08 Million	€-2.27 Million ≈ $-2.66 Million	-0.376x	-110.78%
2009-12-31	€-296.00K ≈ $-346.06K	€-1.03 Million ≈ $-1.21 Million	3.483x	+584.33%
2008-12-31	€396.30K ≈ $463.31K	€-285.00K ≈ $-333.19K	-0.719x	--

About Glob Bioenergi

PA:ALGBE France Specialty Chemicals

Market Cap

$392.09K

€335.38K EUR

Market Cap Rank

#30875 Global

#587 in France

Share Price

€0.02

Change (1 day)

+0.00%

52-Week Range

€0.02 - €0.99

All Time High

€35.93